Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Chugai Pharmaceutical Co Ltd    4519   JP3519400000

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2017 522 B
EBIT 2017 -
Net income 2017 69 661 M
Finance 2017 172 B
Yield 2017 1,12%
Sales 2018 550 B
EBIT 2018 -
Net income 2018 75 380 M
Finance 2018 183 B
Yield 2018 1,22%
P/E ratio 2017 41,89
P/E ratio 2018 38,28
EV / Sales2017 5,36x
EV / Sales2018 5,07x
Capitalization 2 972 B
More Financials
Company
Chugai Pharmaceutical Co., Ltd. engages in the manufacture, sale, import, and export of pharmaceutical.Its products include oncology drugs, bone and joint drugs, renal diseases drugs, and therapeutic antibodies.The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo,... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Surperformance© ratings of Chugai Pharmaceutical Co L
Trading Rating : Investor Rating :
More Ratings
Latest news on CHUGAI PHARMACEUTICAL CO L
10/12 CHUGAI PHARMACEUTICAL : New Breast Cancer Study Findings Reported from Chugai Ph..
10/12 CHUGAI PHARMACEUTICAL : Bispecific Antibody "ERY974" Results of Preclinical Stud..
10/10 CHUGAI PHARMACEUTICAL : Bispecific Antibody 'ERY974' Results of Preclinical Stud..
10/05 CHUGAI PHARMACEUTICAL : Bispecific Antibody "ERY974" Results of Preclinical Stud..
10/05 CHUGAI PHARMACEUTICAL : Bispecific Antibody "ERY974" Results of Preclinical Stud..
09/27 CHUGAI PHARMACEUTICAL : "ALAGLIO® Divided Granules 1.5g," a Photodynamic Diagnos..
09/11 CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Service..
09/08 CHUGAI PHARMACEUTICAL : Filing of Lawsuit on Patent Infringement Concerning Herc..
08/31 CHUGAI PHARMACEUTICAL : Emicizumab Receives Priority Review Designation by FDA f..
08/28 CHUGAI PHARMACEUTICAL : Approval of Actemrafor Additional Indications of Takayas..
More news
Sector news : Pharmaceuticals - NEC
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/05Chugai's Bispecific Antibody "ERY974" Results of Preclinical Study Published .. 
10/05Chugai's Bispecific Antibody "ERY974" Results of Preclinical Study Published .. 
09/11Chugai Pharmaceutical : Contribution of Para-transit Vehicles to Welfare Serv.. 
08/26US FDA grants priority review status to Chugai's BLA for emicizumab to treat .. 
08/24Chugai's Emicizumab Receives Priority Review Designation by FDA f.. 
More tweets
Qtime:15
News from SeekingAlpha
07/27 Chugai Pharmaceutical reports 1H results
07/12 Chugai Pharmaceutical (CHGCY) Presents R&D Conference Call - Slideshow
06/29 Chugai Pharmaceutical (CHGCF) Updates On Projects under Development (R&D Call..
04/29 Chugai Pharmaceutical (CHGCF) Management on Q1 2017 Results - Earnings Call T..
04/26 Chugai Pharmaceutical reports Q1 results
Chart CHUGAI PHARMACEUTICAL CO L
Duration : Period :
Chugai Pharmaceutical Co L Technical Analysis Chart | 4519 | JP3519400000 | 4-Traders
Technical analysis trends CHUGAI PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 4 900  JPY
Spread / Average Target -7,7%
EPS Revisions
Managers
NameTitle
Osamu Nagayama Chairman & Chief Executive Officer
Tatsuro Kosaka President, COO & Representative Director
Yoshio Itaya Chief Financial Officer & Director
Keiji Kono Executive Officer & Manager-IT Supervisory Section
Motoo Ueno Vice Chairman & Head-Audit
Sector and Competitors
1st jan.Capitalization (M$)
CHUGAI PHARMACEUTICAL CO LTD58.27%26 174
JOHNSON & JOHNSON23.29%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER11.58%213 372
MERCK AND COMPANY7.88%173 214